{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:23:47Z","timestamp":1783772627450,"version":"3.55.0"},"reference-count":27,"publisher":"American Chemical Society (ACS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Res. Toxicol."],"published-print":{"date-parts":[[2001,2,1]]},"DOI":"10.1021\/tx0002029","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:54:32Z","timestamp":1027659272000},"page":"175-181","source":"Crossref","is-referenced-by-count":153,"title":["Identification of a Reactive Metabolite of Terbinafine:\u2009 Insights into Terbinafine-Induced Hepatotoxicity"],"prefix":"10.1021","volume":"14","author":[{"given":"Suzanne L.","family":"Iverson","sequence":"first","affiliation":[{"name":"Faculties of Pharmacy and Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack P.","family":"Uetrecht","sequence":"additional","affiliation":[{"name":"Faculties of Pharmacy and Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2001,1,16]]},"reference":[{"key":"tx0002029b00001\/tx0002029b00001_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0190-9622(97)70076-8","volume":"37","author":"Gupta A. K.","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"tx0002029b00002\/tx0002029b00002_1","volume-title":"Oral Terbinafine:\u2009 A New Antifungal Agent. Ann. Pharmacother. 31, 445\u2212456","author":"Abdel-Rahman S. M.","year":"1997"},{"key":"tx0002029b00003\/tx0002029b00003_1","first-page":"67","volume":"23","author":"Gupta A. K.","year":"1998","journal-title":"Clin. Exp. Dermatol."},{"key":"tx0002029b00004\/tx0002029b00004_1","author":"Gupta A. K.","year":"1997","journal-title":"J. Am. Acad. Dermatol. 36 (6, Part 1), 1018\u22121019."},{"key":"tx0002029b00005\/tx0002029b00005_1","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-4362.1998.00496.x","volume":"37","author":"Amichai B.","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"tx0002029b00006\/tx0002029b00006_1","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1997.03890460029004","volume-title":"Safety of oral terbinafine:\u2009 Results of a postmarketing surveillance study in 25884 patients. Arch. Dermatol. 133, 1213\u22121219","author":"Hall M.","year":"1997"},{"key":"tx0002029b00007\/tx0002029b00007_1","unstructured":"Terbinafine Product Monograph, Canada (1995) pp 1\u221233, Dorval, QC, Sandoz, Canada."},{"key":"tx0002029b00008\/tx0002029b00008_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0168-8278(97)82326-4","volume":"26","author":"Erlinger S.","year":"1997","journal-title":"J. Hepatol."},{"key":"tx0002029b00009\/tx0002029b00009_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(97)80492-8","volume":"26","author":"Kenna G. J.","year":"1997","journal-title":"J. Hepatol."},{"key":"tx0002029b00010\/tx0002029b00010_1","volume-title":"Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasia. Toxicol. Appl. Pharmacol. 152 (2), 327\u2212338","author":"Kossor D. C.","year":"1998"},{"key":"tx0002029b00011\/tx0002029b00011_1","unstructured":"Battig, F. A., Nefzger, M., and Schulz, G. (1987) inMajor biotransformation routes of some allylamine antimycotics, pp 479\u2212495, J. R. Prous Science Publishers, S. A., Barcelona, Spain."},{"key":"tx0002029b00012\/tx0002029b00012_1","volume-title":"Clinical pharmacokinetics of terbinafine (Lamisil). Clin. Exp. Dermatol. 14, 110\u2212113","author":"Jensen J. C.","year":"1989"},{"key":"tx0002029b00013\/tx0002029b00013_1","volume-title":"Pharmacokinetics of terbinafine and five known metabolites in children, after oral administration. Biopharm. Drug Dispos. 19, 417\u2212423","author":"Humbert H.","year":"1998"},{"key":"tx0002029b00014\/tx0002029b00014_1","volume-title":"Bioactivation of Foreign Compounds","author":"Kaminsky L. S.","year":"1985"},{"key":"tx0002029b00015\/tx0002029b00015_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(20)82245-5","volume":"239","author":"Omura T.","year":"1964","journal-title":"J. Biol. Chem."},{"key":"tx0002029b00016\/tx0002029b00016_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(96)80273-X","volume":"24","author":"Lazaros G. A.","year":"1996","journal-title":"J. Hepatol."},{"issue":"3","key":"tx0002029b00017\/tx0002029b00017_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.1998.00459.x","volume":"93","author":"Fernandes N. F.","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"tx0002029b00018\/tx0002029b00018_1","volume":"21","author":"Wout J. W.","year":"1994","journal-title":"J. Hepatol."},{"issue":"16","key":"tx0002029b00019\/tx0002029b00019_1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199904223401617","volume":"340","author":"Agarwal K.","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"tx0002029b00020\/tx0002029b00020_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.1997.tb03954.x","volume":"136","author":"Dwyer C. M.","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"tx0002029b00021\/tx0002029b00021_1","volume-title":"Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts. Dig. Dis. Sci. 42 (7), 1486\u22121488","author":"Mallat A.","year":"1997"},{"key":"tx0002029b00022\/tx0002029b00022_1","first-page":"3","volume":"61","author":"Geubel A. P.","year":"1998","journal-title":"Acta Gastro-Enterol. Belg."},{"key":"tx0002029b00023\/tx0002029b00023_1","first-page":"42","volume":"2","author":"Kenna J. G.","year":"1994","journal-title":"Anaesth. Pharmacol. Rev."},{"key":"tx0002029b00024\/tx0002029b00024_1","volume-title":"Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 43, 259\u2212284","author":"Balfour J. A.","year":"1992"},{"key":"tx0002029b00025\/tx0002029b00025_1","doi-asserted-by":"crossref","DOI":"10.1002\/j.1552-4604.1998.tb04447.x","volume":"38","author":"Trepanier E. F.","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"tx0002029b00026\/tx0002029b00026_1","volume-title":"Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions. Drug Metab. Dispos. 27 (9), 1029\u22121038","author":"Vickers A. E.","year":"1999"},{"key":"tx0002029n00001\/tx0002029n00001_1","volume-title":"selective ion monitoring","author":"Abbreviations TBF-A"}],"container-title":["Chemical Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/tx0002029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T19:44:46Z","timestamp":1678823086000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/tx0002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,16]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2,1]]}},"alternative-id":["10.1021\/tx0002029"],"URL":"https:\/\/doi.org\/10.1021\/tx0002029","relation":{},"ISSN":["0893-228X","1520-5010"],"issn-type":[{"value":"0893-228X","type":"print"},{"value":"1520-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1,16]]}}}